These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18215285)

  • 21. Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview.
    Meneses A; Perez-Garcia G; Ponce-Lopez T; Tellez R; Gallegos-Cari A; Castillo C
    Rev Neurosci; 2011; 22(3):365-71. PubMed ID: 21591908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the validity of the use of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder in males and females.
    Bayless DW; Perez MC; Daniel JM
    Behav Brain Res; 2015 Jun; 286():85-92. PubMed ID: 25724583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory deficits and hippocampal cytokine expression in a rat model of ADHD.
    Anderson LG; Vogiatzoglou E; Tang S; Luiz S; Duque T; Ghaly JP; Schwartzer JJ; Hales JB; Sabariego M
    Brain Behav Immun Health; 2024 Feb; 35():100700. PubMed ID: 38107021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple behavioral paradigm to measure impulsive behavior in an animal model of attention deficit hyperactivity disorder (ADHD) of the spontaneously hypertensive rats.
    Kim P; Choi I; Pena IC; Kim HJ; Kwon KJ; Park JH; Han SH; Ryu JH; Cheong JH; Shin CY
    Biomol Ther (Seoul); 2012 Jan; 20(1):125-31. PubMed ID: 24116285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
    Sterley TL; Howells FM; Russell VA
    Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism.
    Kinkead B; Selz KA; Owens MJ; Mandell AJ
    J Neurosci Methods; 2006 Feb; 151(1):68-81. PubMed ID: 16423408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats.
    dela Peña IC; Young Yoon S; Kim Y; Park H; Man Kim K; Hoon Ryu J; Young Shin C; Hoon Cheong J
    Eur J Pharmacol; 2013 Sep; 715(1-3):337-44. PubMed ID: 23707903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; Allie S; Wiggins T
    Behav Brain Res; 2000 Dec; 117(1-2):69-74. PubMed ID: 11099759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of d-amphetamine on short- and long-term memory in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
    Meneses A; Ponce-Lopez T; Tellez R; Gonzalez R; Castillo C; Gasbarri A
    Behav Brain Res; 2011 Jan; 216(1):472-6. PubMed ID: 20813138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylmercury, attention, and memory: baseline-dependent effects of adult d-amphetamine and marginal effects of adolescent methylmercury.
    Kendricks DR; Boomhower SR; Newland MC
    Neurotoxicology; 2020 Sep; 80():130-139. PubMed ID: 32726658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.
    Puumala T; Ruotsalainen S; Jäkälä P; Koivisto E; Riekkinen P; Sirviö J
    Neurobiol Learn Mem; 1996 Sep; 66(2):198-211. PubMed ID: 8946412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotine-induced behavioral sensitization in an adult rat model of attention deficit/hyperactivity disorder (ADHD).
    Watterson E; Spitzer A; Watterson LR; Brackney RJ; Zavala AR; Olive MF; Sanabria F
    Behav Brain Res; 2016 Oct; 312():333-40. PubMed ID: 27363925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spontaneously hypertensive rat/Izm (SHR/Izm) shows attention deficit/hyperactivity disorder-like behaviors but without impulsive behavior: therapeutic implications of low-dose methylphenidate.
    Kishikawa Y; Kawahara Y; Yamada M; Kaneko F; Kawahara H; Nishi A
    Behav Brain Res; 2014 Nov; 274():235-42. PubMed ID: 25151620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): relevance for Attention Deficit/Hyperactivity Disorder (ADHD).
    Pamplona FA; Pandolfo P; Savoldi R; Prediger RD; Takahashi RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1153-60. PubMed ID: 19549550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro.
    Yoon SY; dela Peña I; Kim SM; Woo TS; Shin CY; Son KH; Park H; Lee YS; Ryu JH; Jin M; Kim KM; Cheong JH
    Arch Pharm Res; 2013 Jan; 36(1):134-40. PubMed ID: 23371806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of d-amphetamine on impulsive choice in spontaneously hypertensive and Wistar-Kyoto rats.
    Hand DJ; Fox AT; Reilly MP
    Behav Pharmacol; 2009 Sep; 20(5-6):549-53. PubMed ID: 19654504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
    de Villiers AS; Russell VA; Sagvolden T; Searson A; Jaffer A; Taljaard JJ
    Neurochem Res; 1995 Apr; 20(4):427-33. PubMed ID: 7651580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
    Langen B; Dost R
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.